About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

PRO 140 Prevents Graft-vs-host Disease in Bone Marrow Transplant Recipients

by Anjali Aryamvally on November 26, 2017 at 11:47 AM
Font : A-A+

PRO 140 Prevents Graft-vs-host Disease in Bone Marrow Transplant Recipients

New study offers preclinical proof-of-concept for the ability of PRO 140, a humanized anti-CCR5 monoclonal antibody under development by CytoDyn Inc., to effectively block the development of graft-versus-host disease (GvHD). GvHD is a potentially lethal complication of bone marrow stem cell (BMSC) transplantation. CytoDyn is currently enrolling patients in a Phase 2 clinical trial with PRO 140 for the prevention of GvHD in leukemia patients undergoing BMSC transplantation.

The new publication shows that when immunocompromised mice transplanted with human BMSCs received PRO 140 at a dosing schedule that approximates that being used in the ongoing human clinical trial, the mice showed successful engraftment of human hematopoietic (blood forming) cells without any signs of GvHD. At the same time, control mice all exhibited classical signs of GvHD and none survived (p?0.01). A 10-fold reduction in PRO 140 dose still showed a significant inhibitory effect on GvHD in treated mice, but to a lesser extent.

Advertisement


The study, by Denis R. Burger, Ph.D., CytoDyn Chief Science Officer, and Daniel Lindner, M.D., Ph.D. of the Department of Translational Hematology and Oncology Research, The Cleveland Clinic, has been published in the journal Biology of Blood and Marrow Transplantation.

"This research provided CytoDyn with strong rationale for exploring the use of PRO 140 in its second clinical indication, the prevention of GvHD in BMSC transplantation, following our focus on the treatment of HIV infection," said Dr. Burger. "GvHD is a serious complication that limits the use of BMSC transplantation in patients with blood cancers. The potential of PRO 140 to prevent this life-threatening condition could help extend the use of BMSC transplantation, an important and effective therapy, to more patients."
Advertisement

PRO 140 targets the CCR5 receptor, a molecule that modulates the immune cell trafficking crucial for the development of acute GvHD and other inflammatory conditions. Previous clinical studies by others have shown that blocking CCR5 using a chemical inhibitor can reduce the clinical impact of acute GvHD without significantly affecting the engraftment of transplanted BMSCs. This new study with PRO 140 further supports the concept that the CCR5 receptor on engrafted cells is critical for the development of acute GvHD and that blocking this receptor from recognizing certain immune signaling molecules is a viable approach to mitigating acute GvHD.



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
Turmeric: Magic Ingredient to Keep you Healthy in Winter
Top 7 Benefits of Good Oral Hygiene
Healthy and Safer Thanksgiving 2021
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Bone Marrow Aspiration and Biopsy Leucopenia / Leukopenia Infantile Cortical Hyperostosis Chronic Lymphocytic Leukemia Hodgkins Lymphoma Non-Hodgkins Lymphoma Multiple Myeloma Bone Marrow Transplantation Transplantation Epidermolysis Bullosa 

Recommended Reading
Monoclonal Antibody Given to Preterm Infants Reduces Wheezing Up to 6 Years of Age
The monoclonal antibody palivizumab significantly reduces physician-diagnosed recurrent wheezing up ...
Monoclonal Antibody Therapies may Provide 'Silver Bullet' for Ebola Viruses
There may be a 'silver bullet' for Ebola, a family of hemorrhagic viruses, one of which has killed ....
ANG4043, a Brain-penetrant Peptide-monoclonal Antibody Conjugate, Effective in Treating HER2-positive Intracranial Tumors
Study has revealed that ANG4043, a peptide-monoclonal antibody (mAb) conjugate, entered the brain .....
Monoclonal Antibody Nivolumab Shows Signs of Superior Response Rate in Advanced Melanoma
In patients whose melanoma has progressed after treatment with ipilimumab, the monoclonal antibody ....
Bone Marrow Aspiration and Biopsy
Bone marrow biopsy and aspiration is the removal of some bone marrow tissue for diagnosis and manage...
Bone Marrow Transplantation
Preferred Term is Hematopoietic stem cell transplantation. In this stem cell from bone marrow are in...
Chronic Lymphocytic Leukemia
Chronic Lymphocytic Leukemia (CLL) is one of the most common types of adult leukemia and is consider...
Epidermolysis Bullosa
People with epidermolysis bullosa (EB) develop skin blisters in response to minor injury. EB can occ...
Hodgkins Lymphoma
Hodgkins lymphoma or Hodgkins disease has the distinction of being the first cancer to be cured by c...
Infantile Cortical Hyperostosis
Infantile Cortical Hyperostosis is a disease of unknown cause, where bizarre thickening of the corti...
Leucopenia / Leukopenia
Leucopenia / Leukopenia is a decrease in the number of total white blood cells found in blood. The n...
Multiple Myeloma
Multiple Myeloma caught public attention when model turned actress Lisa Ray, who worked in Deepa Meh...
Non-Hodgkins Lymphoma
Non Hodgkins Lymphoma is a cancer that affects the lymph tissues. It is made up of a wide array of ....
Transplantation
Organ and tissue transplantation can give a second chance at life to thousands of people. Learn more...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use